- Led analysis of In-process, Bulk antigen using diverse analytical techniques.- Quantified process-related impurities, evaluated particle size and osmolality.- Analyzed expression of Quadrivalent  HPV 6L1,11L1,16L1,18L1 vaccine,  releasing  DS  bulk as  per STP.-   Formulated  and  analyzed  Quad rivalent   HPV  Vaccine,  initiating  stability  studies  for   RCGM application.-   Led   Material   generation   testing   by   different   anaytical   techniques… Show more - Led analysis of In-process, Bulk antigen using diverse analytical techniques.- Quantified process-related impurities, evaluated particle size and osmolality.- Analyzed expression of Quadrivalent  HPV 6L1,11L1,16L1,18L1 vaccine,  releasing  DS  bulk as  per STP.-   Formulated  and  analyzed  Quad rivalent   HPV  Vaccine,  initiating  stability  studies  for   RCGM application.-   Led   Material   generation   testing   by   different   anaytical   techniques   and   formulation   of Quad rivalent HPV Vaccine for Toxicity studies.-  Conducted  scientific  literature  survey  and  designed  experiments  for  ongoing  and  upcoming projects.- Trend analysis of stability samples drug substance and drug product Show less

- Evaluated In-process and bulk antigen using various techniques: Colori metric protein quantification, SDS-Gel electrophoresis, Western blot, Dot blot, Particle size analysis.- Quantified process-related impurities ( Host Cell Protein, DNA) and assessed particle size and osmolality.- Analyzed expression of bivalent HPV16L1 & 18L1 vaccine, consistency batches, and prepared formulations for stability studies.- Managed Influenza vaccine… Show more - Evaluated In-process and bulk antigen using various techniques: Colori metric protein quantification, SDS-Gel electrophoresis, Western blot, Dot blot, Particle size analysis.- Quantified process-related impurities ( Host Cell Protein, DNA) and assessed particle size and osmolality.- Analyzed expression of bivalent HPV16L1 & 18L1 vaccine, consistency batches, and prepared formulations for stability studies.- Managed Influenza vaccine polyconal antibody generation in rabbit, titer optimization and IRS qualification for SRID assays.- Prepared sucrose gradient analysis for partial VLP purification in Influenza vaccine. Show less

- Assessed Consistency Quad rivalent Influenza vaccine In-Process and DS bulk antigen using SRID potency assays.- Formulated Quad rivalent Influenza vaccine drug products, organized stability samples for RCGM application.- Analyzed stability samples by SRID assay, compiling regulatory reports for RCGM application.- Conducted Rabies vaccine and Rab One vaccine stability sample analysis by HPLC.- Supported Rabies vaccine clinical trial phase-III human sample… Show more - Assessed Consistency Quad rivalent Influenza vaccine In-Process and DS bulk antigen using SRID potency assays.- Formulated Quad rivalent Influenza vaccine drug products, organized stability samples for RCGM application.- Analyzed stability samples by SRID assay, compiling regulatory reports for RCGM application.- Conducted Rabies vaccine and Rab One vaccine stability sample analysis by HPLC.- Supported Rabies vaccine clinical trial phase-III human sample analysis via RFFIT assay.- Participated in protein expression and virus titer determination using FACS.- Led Immunogenicity experiments for VZV and HPV vaccines, developing antibody quantification methods by ELISA assays. Show less

-   Designed  and  executed   immunogenicity  studies  for   Rabies,   MERS,  and   H.pylori  vaccines, optimizing doses and preclinical activities.- Evaluated In-Process and bulk antigen samples using SRID potency assays.- Formulated Trivalent & Quad rivalent Influenza vaccines for proof of concept and stability studies.- Generated polyclonal HA-specific antibodies in rabbits, optimizing titer by SRID.- Led comparisons of NIBSC and In-House antibodies for HA… Show more -   Designed  and  executed   immunogenicity  studies  for   Rabies,   MERS,  and   H.pylori  vaccines, optimizing doses and preclinical activities.- Evaluated In-Process and bulk antigen samples using SRID potency assays.- Formulated Trivalent & Quad rivalent Influenza vaccines for proof of concept and stability studies.- Generated polyclonal HA-specific antibodies in rabbits, optimizing titer by SRID.- Led comparisons of NIBSC and In-House antibodies for HA evaluation in Influenza vaccine.-  Conducted tumor  model  experiments,  dosing,  bleeding,  ELISPOT  assays,  and  IHC  staining for cancer drug screening. Show less

-  Led  analysis  and  timely  release  of  In-Process  and  Drug  products,  spanning  Streptokinase, Erythropoietin, GCSF, heat-killed Mycobacterium, recombinant Rabies G Protein Vaccine, Trivalent Influenza vaccine, and RSV vaccine.-  Applied  protein  estimation  techniques  ( BCA,  Micro-BCA,  OD280,  Folin  Lowry,  Bradford)  for accurate protein quantification across biotech products.-  Executed stability studies sample analysis  using techniques such as SDS-PAGE, silver… Show more -  Led  analysis  and  timely  release  of  In-Process  and  Drug  products,  spanning  Streptokinase, Erythropoietin, GCSF, heat-killed Mycobacterium, recombinant Rabies G Protein Vaccine, Trivalent Influenza vaccine, and RSV vaccine.-  Applied  protein  estimation  techniques  ( BCA,  Micro-BCA,  OD280,  Folin  Lowry,  Bradford)  for accurate protein quantification across biotech products.-  Executed stability studies sample analysis  using techniques such as SDS-PAGE, silver staining, and Isoelectric focusing.- Conducted protein identification via Western blot technique.- Employed Immuno-precipitation methods ( DID and SRID potency assay) for antigen identification and quantification.-   Orchestrated   In-House   reference   standard   qualification,   antibody   titer   optimization,   and preparation of ROA and COA.-  Managed  reconciliation  records  of  In-house  and  National  Reference  standards,  antibody,  and maintained equipment logs.- Prepared buffers, reagents, STPs, and SOPs in line with Good Laboratory Practices.-  Contributed  to  data  review,  calibration,  and  maintaining  laboratory  compliance  with  good documentation practices. Show less

- analysis and timely release of In-Process and Drug products, spanning Streptokinase, Erythropoietin, GCSF, heat-killed Mycobacterium, recombinant Rabies G Protein Vaccine, Trivalent Influenza vaccine, and RSV vaccine.- Applied protein estimation techniques ( BCA, Micro-BCA, OD280, Folin Lowry, Bradford) for accurate protein quantification across biotech products.- Executed stability studies sample analysis using techniques such as SDS-PAGE, silver staining, and… Show more - analysis and timely release of In-Process and Drug products, spanning Streptokinase, Erythropoietin, GCSF, heat-killed Mycobacterium, recombinant Rabies G Protein Vaccine, Trivalent Influenza vaccine, and RSV vaccine.- Applied protein estimation techniques ( BCA, Micro-BCA, OD280, Folin Lowry, Bradford) for accurate protein quantification across biotech products.- Executed stability studies sample analysis using techniques such as SDS-PAGE, silver staining, and Isoelectric focusing.- Conducted protein identification via Western blot technique.- Employed Immuno-precipitation methods ( DID and SRID potency assay) for antigen identification and quantification.- Orchestrated In-House reference standard qualification, antibody titer optimization, and preparation of ROA and COA.- Managed reconciliation records of In-house and National Reference standards, antibody, and maintained equipment logs.- Prepared buffers, reagents, STPs, and SOPs in line with Good Laboratory Practices.- Contributed to data review, calibration, and maintaining laboratory compliance with good documentation practices. Show less